Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 19 | 2022 | 643 | 1.720 |
Why?
|
| Mitochondria, Liver | 14 | 2013 | 148 | 1.690 |
Why?
|
| Mitochondria, Heart | 7 | 2021 | 53 | 1.120 |
Why?
|
| Calcium | 15 | 2013 | 929 | 1.090 |
Why?
|
| Antineoplastic Agents | 7 | 2022 | 1070 | 1.000 |
Why?
|
| Diazoxide | 6 | 2012 | 9 | 0.850 |
Why?
|
| Hepatocytes | 4 | 2013 | 205 | 0.830 |
Why?
|
| Ventricular Fibrillation | 1 | 2022 | 85 | 0.810 |
Why?
|
| Voltage-Dependent Anion Channels | 4 | 2012 | 40 | 0.810 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 239 | 0.730 |
Why?
|
| Fibroblasts | 4 | 2018 | 902 | 0.710 |
Why?
|
| Potassium Channels | 6 | 2004 | 55 | 0.680 |
Why?
|
| Cardiotonic Agents | 2 | 2012 | 71 | 0.650 |
Why?
|
| Rats | 25 | 2022 | 5300 | 0.620 |
Why?
|
| Oxidative Phosphorylation | 8 | 2021 | 54 | 0.570 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 108 | 0.560 |
Why?
|
| Cell Differentiation | 3 | 2018 | 1034 | 0.560 |
Why?
|
| Oxidative Stress | 4 | 2021 | 718 | 0.550 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1533 | 0.540 |
Why?
|
| Mitochondrial Membranes | 4 | 2010 | 45 | 0.540 |
Why?
|
| Ethanol | 3 | 2012 | 892 | 0.530 |
Why?
|
| Adenosine Triphosphate | 11 | 2018 | 314 | 0.510 |
Why?
|
| Peptide Fragments | 1 | 2017 | 483 | 0.500 |
Why?
|
| Animals | 35 | 2022 | 20880 | 0.480 |
Why?
|
| Sarcolemma | 2 | 2012 | 16 | 0.480 |
Why?
|
| Myocardium | 5 | 2015 | 1204 | 0.470 |
Why?
|
| Myocytes, Cardiac | 4 | 2022 | 442 | 0.450 |
Why?
|
| Myofibrils | 1 | 2012 | 35 | 0.430 |
Why?
|
| Acetaldehyde | 1 | 2012 | 18 | 0.410 |
Why?
|
| Urea | 1 | 2012 | 51 | 0.400 |
Why?
|
| Aging | 4 | 2022 | 911 | 0.400 |
Why?
|
| Dendrimers | 2 | 2009 | 12 | 0.400 |
Why?
|
| Biological Transport | 4 | 2008 | 210 | 0.390 |
Why?
|
| Models, Biological | 6 | 2011 | 981 | 0.370 |
Why?
|
| Central Nervous System Depressants | 1 | 2012 | 182 | 0.360 |
Why?
|
| Energy Metabolism | 3 | 2021 | 222 | 0.340 |
Why?
|
| Permeability | 6 | 2010 | 131 | 0.340 |
Why?
|
| Mitochondrial Proteins | 3 | 2022 | 113 | 0.320 |
Why?
|
| Cytostatic Agents | 1 | 2007 | 4 | 0.310 |
Why?
|
| Polypropylenes | 1 | 2007 | 31 | 0.300 |
Why?
|
| Simvastatin | 2 | 2018 | 34 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2013 | 2083 | 0.290 |
Why?
|
| Endothelial Cells | 2 | 2007 | 384 | 0.290 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2018 | 126 | 0.270 |
Why?
|
| Calcium Signaling | 2 | 2006 | 97 | 0.260 |
Why?
|
| DNA, Mitochondrial | 2 | 2022 | 84 | 0.260 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 248 | 0.260 |
Why?
|
| Oxygen | 3 | 2005 | 386 | 0.250 |
Why?
|
| Cells, Cultured | 9 | 2018 | 2673 | 0.250 |
Why?
|
| Oxygen Consumption | 6 | 2012 | 258 | 0.250 |
Why?
|
| Homeostasis | 1 | 2006 | 291 | 0.250 |
Why?
|
| Uncoupling Agents | 1 | 2004 | 10 | 0.240 |
Why?
|
| Heart Atria | 4 | 2018 | 206 | 0.240 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 562 | 0.240 |
Why?
|
| Reperfusion Injury | 3 | 2013 | 320 | 0.230 |
Why?
|
| Endopeptidase Clp | 2 | 2022 | 4 | 0.230 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 499 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 1851 | 0.220 |
Why?
|
| Membrane Potentials | 8 | 2007 | 200 | 0.210 |
Why?
|
| 4-Aminopyridine | 1 | 2022 | 5 | 0.210 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2002 | 11 | 0.210 |
Why?
|
| Tetrodotoxin | 1 | 2022 | 26 | 0.210 |
Why?
|
| Calcium Channels | 3 | 2013 | 59 | 0.210 |
Why?
|
| Isoproterenol | 1 | 2022 | 163 | 0.210 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 41 | 0.210 |
Why?
|
| Intracellular Membranes | 4 | 1998 | 86 | 0.200 |
Why?
|
| Sodium | 1 | 2022 | 161 | 0.200 |
Why?
|
| Action Potentials | 1 | 2022 | 223 | 0.190 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 61 | 0.190 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2000 | 16 | 0.190 |
Why?
|
| Cell Respiration | 3 | 2015 | 47 | 0.190 |
Why?
|
| Minocycline | 2 | 2013 | 61 | 0.180 |
Why?
|
| NIH 3T3 Cells | 2 | 2017 | 65 | 0.180 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 26 | 0.180 |
Why?
|
| Creatine | 1 | 2019 | 30 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1174 | 0.180 |
Why?
|
| Transcriptome | 1 | 2021 | 164 | 0.180 |
Why?
|
| Strontium | 5 | 1995 | 10 | 0.170 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 63 | 0.170 |
Why?
|
| src-Family Kinases | 1 | 2019 | 91 | 0.170 |
Why?
|
| CD52 Antigen | 1 | 2019 | 2 | 0.170 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 34 | 0.170 |
Why?
|
| Male | 13 | 2022 | 37283 | 0.170 |
Why?
|
| Cyclopropanes | 1 | 1998 | 10 | 0.170 |
Why?
|
| Oxadiazoles | 1 | 1998 | 7 | 0.170 |
Why?
|
| Microscopy, Electron | 3 | 2012 | 351 | 0.160 |
Why?
|
| Gene Editing | 1 | 2019 | 33 | 0.160 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 3 | 0.160 |
Why?
|
| Epitopes | 1 | 2019 | 146 | 0.160 |
Why?
|
| Humans | 21 | 2022 | 68549 | 0.160 |
Why?
|
| Smad3 Protein | 1 | 2018 | 33 | 0.160 |
Why?
|
| Smad2 Protein | 1 | 2018 | 42 | 0.160 |
Why?
|
| Quinoxalines | 1 | 1998 | 78 | 0.160 |
Why?
|
| Protein Phosphatase 2 | 1 | 2018 | 67 | 0.160 |
Why?
|
| Anti-Anxiety Agents | 1 | 1998 | 107 | 0.150 |
Why?
|
| Oxidation-Reduction | 5 | 2011 | 567 | 0.150 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2017 | 30 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 332 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2017 | 42 | 0.150 |
Why?
|
| Signal Transduction | 4 | 2017 | 2689 | 0.150 |
Why?
|
| Organothiophosphorus Compounds | 1 | 1996 | 1 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 114 | 0.140 |
Why?
|
| Cholinergic Antagonists | 1 | 1996 | 17 | 0.140 |
Why?
|
| Nitric Oxide | 2 | 2009 | 382 | 0.140 |
Why?
|
| Hydroquinones | 2 | 2007 | 15 | 0.140 |
Why?
|
| Superoxides | 3 | 2016 | 70 | 0.140 |
Why?
|
| Insecticides | 1 | 1996 | 43 | 0.140 |
Why?
|
| Collagen Type I | 1 | 2017 | 175 | 0.140 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 7 | 0.140 |
Why?
|
| Adamantane | 2 | 2007 | 40 | 0.140 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 142 | 0.140 |
Why?
|
| Tetracycline | 2 | 2013 | 29 | 0.130 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1082 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 1999 | 617 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.120 |
Why?
|
| Kinetics | 4 | 2008 | 1047 | 0.120 |
Why?
|
| Liver | 2 | 2008 | 1118 | 0.120 |
Why?
|
| Cell Movement | 1 | 2017 | 630 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2015 | 954 | 0.120 |
Why?
|
| In Vitro Techniques | 6 | 2018 | 765 | 0.120 |
Why?
|
| Cyclosporine | 2 | 2008 | 121 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 852 | 0.110 |
Why?
|
| Doxycycline | 1 | 2013 | 49 | 0.110 |
Why?
|
| Citrate (si)-Synthase | 1 | 2012 | 11 | 0.110 |
Why?
|
| Pinacidil | 2 | 2004 | 2 | 0.110 |
Why?
|
| Superoxide Dismutase | 2 | 2021 | 149 | 0.100 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2013 | 41 | 0.100 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Enzyme Activators | 1 | 2012 | 14 | 0.100 |
Why?
|
| Mice | 3 | 2022 | 8474 | 0.100 |
Why?
|
| Catalase | 1 | 2012 | 85 | 0.100 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2012 | 32 | 0.100 |
Why?
|
| Serine | 1 | 2011 | 99 | 0.100 |
Why?
|
| Glycolysis | 1 | 2011 | 79 | 0.100 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 191 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 498 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1293 | 0.100 |
Why?
|
| NAD | 1 | 2011 | 73 | 0.100 |
Why?
|
| Potassium | 4 | 2000 | 168 | 0.100 |
Why?
|
| Female | 7 | 2022 | 38021 | 0.090 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2010 | 3 | 0.090 |
Why?
|
| Thionucleotides | 1 | 2010 | 21 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.090 |
Why?
|
| Polyamines | 1 | 2009 | 79 | 0.090 |
Why?
|
| Digitonin | 1 | 2008 | 5 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 1026 | 0.080 |
Why?
|
| Silicon Dioxide | 1 | 2008 | 61 | 0.080 |
Why?
|
| Glutathione | 1 | 2009 | 343 | 0.080 |
Why?
|
| Antioxidants | 1 | 2010 | 304 | 0.070 |
Why?
|
| Adenosine Diphosphate | 3 | 2008 | 66 | 0.070 |
Why?
|
| Drug Carriers | 1 | 2008 | 90 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2006 | 618 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 133 | 0.070 |
Why?
|
| Biological Clocks | 1 | 2006 | 6 | 0.070 |
Why?
|
| Rats, Inbred F344 | 2 | 2021 | 104 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2010 | 706 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2007 | 524 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2005 | 59 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2015 | 1200 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 212 | 0.060 |
Why?
|
| Cell Survival | 3 | 2019 | 901 | 0.060 |
Why?
|
| Valinomycin | 2 | 1999 | 3 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2008 | 254 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2008 | 400 | 0.060 |
Why?
|
| Cellular Senescence | 2 | 2018 | 112 | 0.050 |
Why?
|
| Stem Cells | 1 | 2004 | 248 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 1027 | 0.050 |
Why?
|
| Ditiocarb | 1 | 2022 | 1 | 0.050 |
Why?
|
| Entosis | 1 | 2022 | 1 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 59 | 0.050 |
Why?
|
| Disulfiram | 1 | 2022 | 22 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 82 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2022 | 80 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 137 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2021 | 20 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1663 | 0.050 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2021 | 41 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 94 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 541 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 73 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 49 | 0.050 |
Why?
|
| Ion Transport | 1 | 2000 | 26 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 94 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 92 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 21119 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2000 | 167 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 236 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 138 | 0.050 |
Why?
|
| Drug Design | 1 | 2000 | 107 | 0.040 |
Why?
|
| Tetramethylphenylenediamine | 2 | 1996 | 2 | 0.040 |
Why?
|
| Ionophores | 1 | 1999 | 25 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 111 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2019 | 73 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 376 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 35 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 92 | 0.040 |
Why?
|
| Rhodamine 123 | 1 | 1998 | 13 | 0.040 |
Why?
|
| Transfection | 1 | 2000 | 782 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 191 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 218 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 14842 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 1999 | 337 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 1998 | 42 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Imidazoles | 1 | 2019 | 175 | 0.040 |
Why?
|
| Species Specificity | 1 | 1998 | 302 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 1998 | 204 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2019 | 311 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 67 | 0.040 |
Why?
|
| Rabbits | 1 | 1998 | 509 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 326 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2019 | 178 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 791 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 8904 | 0.040 |
Why?
|
| Pyridines | 1 | 2019 | 261 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1745 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 614 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 1996 | 45 | 0.040 |
Why?
|
| Acyl Coenzyme A | 1 | 2016 | 6 | 0.040 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2016 | 11 | 0.040 |
Why?
|
| K562 Cells | 2 | 2007 | 44 | 0.030 |
Why?
|
| G1 Phase | 1 | 2016 | 42 | 0.030 |
Why?
|
| Mevalonic Acid | 1 | 2016 | 27 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 1860 | 0.030 |
Why?
|
| Cyclins | 1 | 2016 | 50 | 0.030 |
Why?
|
| Aldehydes | 1 | 2016 | 34 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1995 | 13 | 0.030 |
Why?
|
| Glycogen | 1 | 2015 | 27 | 0.030 |
Why?
|
| Ion-Selective Electrodes | 1 | 1995 | 2 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 185 | 0.030 |
Why?
|
| Protons | 1 | 1995 | 57 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 196 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 447 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1995 | 371 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1593 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2004 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 318 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 4655 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 1037 | 0.030 |
Why?
|
| Hypoxia | 1 | 2013 | 169 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1549 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2011 | 54 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 21379 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2016 | 738 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1998 | 3187 | 0.020 |
Why?
|
| Iron | 1 | 2013 | 197 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 114 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5710 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5720 | 0.020 |
Why?
|
| Proton-Translocating ATPases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 24 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2008 | 150 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 137 | 0.020 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Peroxides | 1 | 2007 | 23 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 239 | 0.020 |
Why?
|
| Electron Transport | 1 | 2007 | 37 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 4843 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 320 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 710 | 0.020 |
Why?
|
| Starvation | 1 | 1986 | 8 | 0.020 |
Why?
|
| Cations | 1 | 1986 | 51 | 0.020 |
Why?
|
| Graft Survival | 1 | 2008 | 465 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 420 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2004 | 14 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2004 | 54 | 0.020 |
Why?
|
| Genes | 1 | 2004 | 86 | 0.020 |
Why?
|
| Lipids | 1 | 1986 | 298 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1982 | 20 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1982 | 38 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2550 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2004 | 313 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 946 | 0.010 |
Why?
|
| Adenylate Kinase | 1 | 2001 | 10 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 1982 | 209 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1641 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 1664 | 0.010 |
Why?
|
| Ruthenium Red | 1 | 1998 | 5 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 1998 | 12 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 1998 | 114 | 0.010 |
Why?
|
| Pyruvates | 1 | 1995 | 4 | 0.010 |
Why?
|
| Malates | 1 | 1995 | 5 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 1995 | 9 | 0.010 |
Why?
|
| Succinic Acid | 1 | 1995 | 9 | 0.010 |
Why?
|
| Succinates | 1 | 1995 | 9 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1995 | 63 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1995 | 40 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1995 | 60 | 0.010 |
Why?
|
| Oocytes | 1 | 1995 | 57 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 62 | 0.000 |
Why?
|
| Chemistry | 1 | 1986 | 45 | 0.000 |
Why?
|
| Phospholipids | 1 | 1986 | 108 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 532 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1986 | 222 | 0.000 |
Why?
|
| Hydrogen | 1 | 1982 | 35 | 0.000 |
Why?
|
| Ion Channels | 1 | 1982 | 72 | 0.000 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1982 | 84 | 0.000 |
Why?
|